190 related articles for article (PubMed ID: 32808825)
1. Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease.
Di Pasquale M; Aliberti S; Mantero M; Gramegna A; Blasi F
Expert Opin Pharmacother; 2020 Nov; 21(16):1975-1990. PubMed ID: 32808825
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for lower respiratory tract infections.
Liapikou A; Torres A
Expert Opin Pharmacother; 2014 Nov; 15(16):2307-18. PubMed ID: 25216725
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
Wilson R; Sethi S; Anzueto A; Miravitlles M
J Infect; 2013 Dec; 67(6):497-515. PubMed ID: 23973659
[TBL] [Abstract][Full Text] [Related]
4. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
Laska IF; Crichton ML; Shoemark A; Chalmers JD
Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
[TBL] [Abstract][Full Text] [Related]
7. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
8. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
[TBL] [Abstract][Full Text] [Related]
9. [Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].
Rohde GGU; Welte T
Internist (Berl); 2017 Nov; 58(11):1142-1149. PubMed ID: 28983645
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients.
Lee E; Hong SJ
Expert Opin Pharmacother; 2019 Jun; 20(8):1025-1036. PubMed ID: 30897021
[TBL] [Abstract][Full Text] [Related]
11. Inhaled antimicrobial therapy - barriers to effective treatment.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
[TBL] [Abstract][Full Text] [Related]
12. To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial.
Gao J; Gao X; Kong L
Trials; 2014 Apr; 15():150. PubMed ID: 24773830
[TBL] [Abstract][Full Text] [Related]
13. Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To
Montón C; Prina E; Pomares X; Cugat JR; Casabella A; Oliva JC; Gallego M; Monsó E
Int J Chron Obstruct Pulmon Dis; 2019; 14():2365-2373. PubMed ID: 31802860
[TBL] [Abstract][Full Text] [Related]
14. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis.
Aksamit T; Bandel TJ; Criollo M; De Soyza A; Elborn JS; Operschall E; Polverino E; Roth K; Winthrop KL; Wilson R
Contemp Clin Trials; 2017 Jul; 58():78-85. PubMed ID: 28495619
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
Grimwood K; Bell SC; Chang AB
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
[TBL] [Abstract][Full Text] [Related]
16. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.
Steinfort DP; Steinfort C
Intern Med J; 2007 Jul; 37(7):495-8. PubMed ID: 17547727
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of non-cystic fibrosis bronchiectasis].
Martínez García MÁ; Máiz Carro L; Catalán Serra P
Arch Bronconeumol; 2011 Dec; 47(12):599-609. PubMed ID: 21798654
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Siekmeier R; Hofmann T; Scheuch G
Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
[TBL] [Abstract][Full Text] [Related]
20. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review.
Brodt AM; Stovold E; Zhang L
Eur Respir J; 2014 Aug; 44(2):382-93. PubMed ID: 24925920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
